Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-2-24
pubmed:abstractText
The aim of the study was to determine the prevalence of hepatitis E virus (HEV) infection among individuals at high risk of transmission of non-A, non-B hepatitis or sexually transmitted diseases (STDs), and to evaluate whether they have an increased risk of exposure to HEV. Serum samples from 125 thalassemia patients, 300 intravenous drug users, 420 hemodialysis patients, 263 individuals with STDs, 47 human immunodeficiency virus (HIV) infected homosexual men, and 316 healthy volunteers were tested for immunoglobulin G (IgG) and M (IgM) antibodies to HEV (anti-HEV) by enzyme immunoassays (EIAs) following a predetermined algorithm (Abbott Labs). Anti-HEV IgG was confirmed in 3/125 (2.4%) thalassemia patients, 5/300 (1.7%) intravenous drug users, 27/420 (6.4%) hemodialysis patients, 4/263 (1.5%) STD patients, 1/47 (2.1%) homosexual men, and 7/316 (2.2%) of the reference group. No patient was found positive for anti-HEV IgM. The higher prevalence which was observed in hemodialysis group was due to the confounding effect of age, as multivariate analysis showed. The anti-HEV prevalence increased significantly with age (p = 10(-4)). No significant association was found between anti-HEV, anti-HCV, and anti-HBc. In conclusion, individuals at high risk of non-A, non-B hepatitis and STDs have no increased risk of exposure to HEV and the higher prevalence of anti-HEV IgG among older subjects may be due to an epidemic form of HEV infection which occurred some decades ago, when the sanitary conditions in our country were poor.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0036-5548
pubmed:author
pubmed:issnType
Print
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
443-5
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8953670-Adolescent, pubmed-meshheading:8953670-Adult, pubmed-meshheading:8953670-Aged, pubmed-meshheading:8953670-Aged, 80 and over, pubmed-meshheading:8953670-Child, pubmed-meshheading:8953670-Child, Preschool, pubmed-meshheading:8953670-Disease Transmission, Infectious, pubmed-meshheading:8953670-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:8953670-Female, pubmed-meshheading:8953670-Hepacivirus, pubmed-meshheading:8953670-Hepatitis Antibodies, pubmed-meshheading:8953670-Hepatitis C, pubmed-meshheading:8953670-Hepatitis C Antibodies, pubmed-meshheading:8953670-Hepatitis E, pubmed-meshheading:8953670-Hepatitis E virus, pubmed-meshheading:8953670-Humans, pubmed-meshheading:8953670-Immunoglobulin M, pubmed-meshheading:8953670-Infant, pubmed-meshheading:8953670-Male, pubmed-meshheading:8953670-Middle Aged, pubmed-meshheading:8953670-Prevalence, pubmed-meshheading:8953670-Risk Factors, pubmed-meshheading:8953670-Sexually Transmitted Diseases
pubmed:year
1996
pubmed:articleTitle
Hepatitis E virus infection in individuals at high risk of transmission of non-A, non-B hepatitis and sexually transmitted diseases.
pubmed:affiliation
Department of Hygiene and Epidemiology, Athens University Medical School, Greece.
pubmed:publicationType
Journal Article